NovaQuest Pharma Opportunities Fund V (Delaware), L.P. is a private equity fund based in Raleigh, North Carolina. According to its most recent Form D, filed Jun 21, 2019, it has sold $892,750,000 of interests to 1 investor since its first sale in Jun 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Ronald Wooten; Ernest Brown; Manabu Ikegami.
- Total raised
- $892,750,000Cumulative sales reported on Form D
- Investors
- 1
- First sale
- Jun 28, 2017
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Ronald Wooten; Ernest Brown; Manabu Ikegami
- Latest Form D
- Jun 21, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Jun 21, 2019 | Amendment | $892,750,000 | 1 | SEC.gov ↗ |
| Jun 22, 2018 | Amendment | $746,750,000 | 0 | SEC.gov ↗ |
| Jun 23, 2017 | First notice | $0 | 0 | SEC.gov ↗ |
3 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 23, 2017. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about NovaQuest Pharma Opportunities Fund V (Delaware), L.P.
What is the minimum investment for NovaQuest Pharma Opportunities Fund V (Delaware), L.P.?
NovaQuest Pharma Opportunities Fund V (Delaware), L.P.'s latest Form D, filed Jun 21, 2019, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in NovaQuest Pharma Opportunities Fund V (Delaware), L.P.?
NovaQuest Pharma Opportunities Fund V (Delaware), L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has NovaQuest Pharma Opportunities Fund V (Delaware), L.P. raised?
NovaQuest Pharma Opportunities Fund V (Delaware), L.P. reports $892,750,000 sold from 1 investor on its Form D filed Jun 21, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is NovaQuest Pharma Opportunities Fund V (Delaware), L.P. based?
NovaQuest Pharma Opportunities Fund V (Delaware), L.P. is based in Raleigh, North Carolina.
When did NovaQuest Pharma Opportunities Fund V (Delaware), L.P. launch?
NovaQuest Pharma Opportunities Fund V (Delaware), L.P. reports its first sale in Jun 2017.
Size compared with every private equity fund
Raised more than 97% of the 79 private equity funds based in North Carolina, and more than 94% of all 8,950 that report sales.